1. Home
  2. FGEN vs HSON Comparison

FGEN vs HSON Comparison

Compare FGEN & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • HSON
  • Stock Information
  • Founded
  • FGEN 1993
  • HSON 1999
  • Country
  • FGEN United States
  • HSON United States
  • Employees
  • FGEN N/A
  • HSON N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • HSON Professional Services
  • Sector
  • FGEN Health Care
  • HSON Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • HSON Nasdaq
  • Market Cap
  • FGEN 33.5M
  • HSON 26.1M
  • IPO Year
  • FGEN 2014
  • HSON N/A
  • Fundamental
  • Price
  • FGEN $7.26
  • HSON $8.72
  • Analyst Decision
  • FGEN Strong Buy
  • HSON
  • Analyst Count
  • FGEN 1
  • HSON 0
  • Target Price
  • FGEN $250.00
  • HSON N/A
  • AVG Volume (30 Days)
  • FGEN 74.1K
  • HSON 14.9K
  • Earning Date
  • FGEN 08-05-2025
  • HSON 08-07-2025
  • Dividend Yield
  • FGEN N/A
  • HSON N/A
  • EPS Growth
  • FGEN N/A
  • HSON N/A
  • EPS
  • FGEN N/A
  • HSON N/A
  • Revenue
  • FGEN $6,996,000.00
  • HSON $138,031,000.00
  • Revenue This Year
  • FGEN N/A
  • HSON $0.80
  • Revenue Next Year
  • FGEN N/A
  • HSON $8.09
  • P/E Ratio
  • FGEN N/A
  • HSON N/A
  • Revenue Growth
  • FGEN N/A
  • HSON N/A
  • 52 Week Low
  • FGEN $4.50
  • HSON $8.28
  • 52 Week High
  • FGEN $38.25
  • HSON $18.99
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 60.54
  • HSON 42.64
  • Support Level
  • FGEN $5.37
  • HSON $8.35
  • Resistance Level
  • FGEN $5.73
  • HSON $8.80
  • Average True Range (ATR)
  • FGEN 0.49
  • HSON 0.33
  • MACD
  • FGEN 0.27
  • HSON 0.05
  • Stochastic Oscillator
  • FGEN 83.80
  • HSON 27.69

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: